A Real-World Cohort Study of EGFR TKIs in Patients with NSCLC with Uncommon EGFR mutations (UpSwinG)

被引：2
|
作者：
Miura, S. [1 ]
Hsia, T. [2 ]
Hung, J. [3 ]
Jung, H. A. [4 ]
Shih, J. [5 ]
Park, C. [6 ,7 ]
Lee, S. H. [8 ]
Okamoto, T. [9 ]
Ahn, H. K. [10 ]
Lee, Y. C. [11 ]
Sato, Y. [12 ]
Lee, S. S. [13 ]
Mascaux, C. [14 ]
Daoud, H. [15 ]
Maerten, A. [15 ]
Popat, S. [16 ,17 ]
机构：
[1] Niigata Canc Ctr Hosp, Dept Internal Med, Niigata, Japan
[2] China Med Univ, Dept Resp Therapy, Dept Internal Med, China Med Univ Hosp, Taichung, Taiwan
[3] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Kaohsiung, Taiwan
[4] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea
[5] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
[6] Chonnam Natl Univ, Sch Med, Dept Internal Med, Hwasun, South Korea
[7] Hwasun Hosp, Hwasun, South Korea
[8] Kyung Hee Univ, Sch Med, Div Pulm & Crit Care Med, Dept Internal Med,Med Ctr, Seoul, South Korea
[9] Natl Hosp Org Kyushu Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan
[10] Gachon Univ, Gil Med Ctr, Div Med Oncol, Incheon, South Korea
[11] Chonbuk Natl Univ, Res Inst Clin Med, Biomed Res Inst, Dept Internal Med,Chonbuk Natl Univ Hosp,Med Sch, Jeonju, South Korea
[12] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo, Japan
[13] Inje Univ, Coll Med, Haeundae Paik Hosp, Busan, South Korea
[14] Strasbourg Univ, Strasbourg Univ Hosp, Dept Pulm, Strasbourg, France
[15] Boehringer Ingelheim Int Gmbh, Ingelheim, Germany
[16] Royal Marsden Natl Hlth Serv Fdn Trust, Lung Unit, London, England
[17] Inst Canc Res, London, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
D O I：
10.1016/j.jtho.2021.08.531
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P50.03
引用
收藏
页码：S1115 / S1116
页数：2
相关论文
共 50 条
  • [31] Clinicopathologic characteristics of NSCLC patients with uncommon EGFR mutations in Korea
    Lee, Yoo Jung
    Yeo, Chang Dong
    Park, Chan Kwon
    Kim, Sung Kyoung
    Kim, Ju Sang
    Kim, Yong Hyun
    Kim, Jin Woo
    Kim, Seung Joon
    Lee, Sang Haak
    Kang, Hye Seon
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [32] Investigation of age and smoking in NSCLC patients with uncommon EGFR mutations
    Maezawa, Yosuke
    Taguchi, Manato
    Kawakami, Takeshi
    Inui, Toshihide
    Okauchi, Shinichiro
    Numata, Takeshi
    Shiozawa, Toshihiro
    Miyazaki, Kunihiko
    Nakamura, Ryota
    Iguchi, Kesato
    Endo, Takeo
    Sakamoto, Tohru
    Satoh, Hiroaki
    Hizawa, Nobuyuki
    [J]. TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2024, 72 (02): : 107 - 113
  • [33] Clinicopathologic characteristics of NSCLC patients with uncommon EGFR mutations in Korea
    Kang, Hye Seon
    Kim, Kyu Yeon
    Lim, Jeong Uk
    Yeo, Chang Dong
    Kim, Ju Sang
    Kim, Seung Joon
    Lee, Sang Haak
    [J]. RESPIROLOGY, 2023, 28 : 100 - 100
  • [34] Frequency and Detectability of Uncommon EGFR Mutations in NSCLC
    O'Sullivan, H. M.
    MacMahon, S.
    Cui, W.
    Milner-Watts, C.
    Tokaca, N.
    Bhosle, J.
    Davidson, M.
    Minchom, A.
    Yousaf, N.
    O'Brien, M.
    Popat, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S88 - S89
  • [35] Obesity has an impact on the efficacy of EGFR-TKI in NSCLC patients harbouring EGFR mutation: A real-world study
    Ding, Z-Y.
    Chen, Y-Y.
    Hong, Y.
    Tong, L-P.
    Li, Q.
    Lin, P-P.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [36] Rare and Common EGFR Mutations in Patients with Advanced NSCLC Treated with EGFR-TKIs: A Registry-Based Study
    Pesek, Milos
    Kolek, Vitezslav
    Skrickova, Jana
    Cernovska, Marketa
    Koubkova, Leona
    Roubec, Jaromir
    Salajka, Frantisek
    Zemanova, Milada
    Krejci, Jana
    Hejduk, Karel
    Ryska, Ales
    Minarik, Marek
    Fiala, Ondrej
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S318 - S318
  • [37] Afatinib in EGFR Mutation-Positive (EGFRm plus ) NSCLC Harbouring Uncommon Mutations: Experience in 'Real-World' Clinical Practice
    Brueckl, W.
    Laack, E.
    Hoffmann, C.
    Zhou, C.
    Wu, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S670 - S671
  • [38] Long-term survival of NSCLC patients with EGFR mutations treated with EGFR TKIs gefitinib or erlotinib
    Janne, R
    Sequist, L
    Lindeman, N
    Bell, D
    Huberman, M
    Meyerson, M
    Haber, D
    Lynch, T
    Johnson, B
    [J]. LUNG CANCER, 2005, 49 : S109 - S109
  • [39] BRAF mutations and fusions in a real-world cohort of NSCLC patients
    Niu, J. J.
    Mauer, E.
    Barrett, A.
    Ashok, A.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1057 - S1057
  • [40] Dermatologic adverse events in EGFR-TKIs: A real-world analysis
    Paton, Emily
    Friedman, Ryan Jeremy
    Cetnar, Jeremy Paul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345